Trilostane
- Generic Name
- Trilostane
- Drug Type
- Small Molecule
- Chemical Formula
- C20H27NO3
- CAS Number
- 13647-35-3
- Unique Ingredient Identifier
- L0FPV48Q5R
Overview
Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It was withdrawn from the United States market in April 1994.
Background
Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome. It was withdrawn from the United States market in April 1994.
Indication
用于治疗皮质醇增多症（库欣综合征），也可用于醛固酮增多症和高雄激素血症。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath